Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data.
Sophie H A E DerksJoost L M JongenEdgar L van der MeerLi Shen HoCleo SlagterArjen JoosseMaja J A de JongeJoost W SchoutenEsther Oomen-de HoopMartin J van den BentAstrid A M van der VeldtPublished in: Cancers (2023)
After 2015, OS significantly improved for patients with MBM, especially with SRT and ICIs. Demonstrating a large survival benefit, ICIs should be considered first after MBM diagnosis, if clinically feasible.